American Vanguard Corporation (AVD)

Market Cap	25.89M -81.9%
Revenue (ttm)	499.39M -5.8%
Net Income	-59.90M
EPS	-2.09
Shares Out	29.55M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	324,463
Open	0.9000
Previous Close	0.9013
Day's Range	0.8451 - 0.9296
52-Week Range	0.8055 - 5.5500
Beta	1.56
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 9, 2026

About AVD

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets synthetic, biological, and biorational products for agricultural, commercial, and consumer uses in the United States and internationally. The company synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection, such as insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liq...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 1969
• Employees: 739
• Stock Exchange: NYSE
• Ticker Symbol: AVD
• Website: https://www.american-vanguard.com

Financial Performance

In 2025, American Vanguard's revenue was $515.11 million, a decrease of -5.88% compared to the previous year's $547.31 million. Losses were -$49.88 million, -60.52% less than in 2024.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Nov 14, 2026

Data Sources Report a data error